BiotechTube
Discover
News
Company
Sign in
BiotechTube
Home
/
MingSight Pharmaceuticals
/
Kai Zhang
KZ
Kai Zhang
Chief Executive Officer
MingSight Pharmaceuticals
Therapeutic Areas
Ophthalmology
Oncology
MingSight Pharmaceuticals Pipeline
Drug
Indication
Phase
MS-553
Diabetic Macular Edema (DME) / Diabetic Retinopathy (DR)
Phase 1b/2
Leadership Team at MingSight Pharmaceuticals
MN
Michael Niesman
Chief Scientific Officer
View full MingSight Pharmaceuticals profile